Trichomonas Vaginalis: Understanding Trichomoniasis, Symptoms, Diagnosis, and Treatment

#### **Introduction** - **Trichomonas vaginalis** is a protozoan parasite responsible for **trichomoniasis**, a sexually transmitted infection (STI). - It is unique among flagellates as it exists **only in the trophozoite stage**; it does not form cysts. - The organism primarily infects the **urogenital tract** of both males and females. ### **Morphology** - **Shape**: Pear-shaped, with an undulating membrane. - **Size**: 7–23 µm in length and 5–12 µm in width. - **Flagella**: Five in total—**four anterior** and **one posterior** attached to the undulating membrane. - **Axostyle**: Runs along the midline of the body and protrudes slightly at the posterior end. - **Nucleus**: Single, oval-shaped, located anteriorly. - **Motility**: Exhibits **rapid, jerky movements** in wet preparations. ### **Life Cycle of Trichomonas vaginalis** - **Only trophozoite stage** is present; no cyst formation occurs. - **Mode of transmission**:**Sexual contact** is the primary mode (vaginal, urethral, or anal intercourse). - Transmission is facilitated by **moist environments**, including fomites (e.g., towels, contaminated medical instruments). - **Vertical transmission** can occur during childbirth. #### **Step-by-Step Life Cycle** - **Infection occurs through sexual transmission** → Trophozoites are introduced into the urogenital tract. - **Trophozoites multiply by binary fission** and colonize the **vagina, cervix, or male urethra and prostate**. - **Survival in genital fluids** → The trophozoites feed on host epithelial cells, leading to inflammation. - **Transmission to new host** via direct sexual contact. #### **Summary of the Life Cycle** **Trophozoite in urogenital tract** → **Binary fission (multiplication)** → **Colonization of urogenital tract** → **Transmission to new host via sexual contact** ### **Pathogenesis** - The parasite **adheres** to vaginal and urethral epithelium using its **undulating membrane and flagella**. - Produces enzymes such as **cystine proteases, lactic acid, and acetic acid**, which cause:**Disruption of normal vaginal flora (Lactobacilli)** - **Reduction of vaginal pH** - **Epithelial cell apoptosis and inflammatory response** - Causes **petechial hemorrhages** on the vaginal mucosa ("strawberry cervix"). - Leads to **vaginal epithelial desquamation**, resulting in severe irritation. ### **Clinical Features** #### **In Females** - **Asymptomatic in 50% of cases** - **Symptomatic cases present with**:**Frothy, yellow-green vaginal discharge** (often foul-smelling) - **Vaginal itching and burning (pruritus)** - **Dysuria (painful urination)** - **Dyspareunia (pain during intercourse)** - **Strawberry cervix** (petechial hemorrhages on vaginal mucosa) #### **In Males** - Mostly **asymptomatic carriers** - Can cause:**Urethritis** (mild irritation or discharge) - **Prostatitis and epididymitis** (rare complications) #### **Complications** - **In pregnant women**, it increases the risk of:**Preterm birth** - **Low birth weight** - **Neonatal pneumonia** or **conjunctivitis** (if transmitted during birth) - Increases susceptibility to **other STIs**, including **HIV**. ### **Diagnosis of Trichomoniasis** #### **Microscopy (Wet Mount Preparation) – First-line Test** - **Motile trophozoites** with **jerky movement** seen under the microscope. - **Sensitivity**: 50–70% (low in asymptomatic cases). #### **Culture (Gold Standard Test)** - **Diamond’s modified media** or **Trichomonas culture kit** - **More sensitive than wet mount** (~95%). #### **Molecular Tests (PCR/Nucleic Acid Amplification Tests – NAATs)** - **Most sensitive and specific** method (~98%). - Recommended for **asymptomatic carriers**. #### **Serology (ELISA, Immunofluorescence Assays)** - Detects **Trichomonas antigens** in vaginal or urethral secretions. - **Less commonly used** than PCR. ### **Treatment of Trichomoniasis** #### **First-Line Treatment** - **Metronidazole (Drug of Choice)****Dosage**:**2 g orally as a single dose** OR - **500 mg orally twice daily for 7 days** - **Cure rate**: >90% - **Tinidazole** (Alternative to Metronidazole)**Dosage**: **2 g orally, single dose** - **More effective** and **fewer side effects** than metronidazole. #### **Special Considerations** - **Pregnant women**:**Metronidazole is safe in the second and third trimesters.** - **Avoid high doses in the first trimester.** - **Metronidazole-resistant cases**:Increase dose to **2 g daily for 3–5 days** - Consider **parenteral (IV) metronidazole** if oral therapy fails. - **Treat sexual partners simultaneously** to prevent reinfection. ### **Prevention and Control** - **Safe sexual practices**:**Use of condoms** significantly reduces transmission. - **Avoidance of multiple sexual partners**. - **Partner screening and treatment** to prevent reinfection. - **Personal hygiene**: Avoid sharing towels or undergarments. - **Proper sterilization of medical instruments** to prevent fomite transmission. --- ### **Key